Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07366086 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pediatric Safety Follow-up Study of Prior Treatment With Romosozumab for Osteogenesis Imperfecta

Name: Pediatric Safety Follow-up Study of Prior Treatment With Romosozumab for Osteogenesis Imperfecta — clinical trial record (NCT07366086)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 3

SponsorAmgen

Started2026-03-18

View on ClinicalTrials.gov ↗

The primary objective of this trial is to evaluate the safety of romosozumab in participants with osteogenesis imperfecta (OI) that have completed Study 20200105, regardless of whether they received investigational product (romosozumab) until the last protocol-specified dose or ended investigational product early.

Amendment history 3 changes detected by DataLookout

2026-06-23

Primary completion moved earlier: 2028-05-21 → 2028-04-19

2026-06-23

Completion moved earlier: 2028-05-21 → 2028-04-19

2026-04-01

Recruitment opened

Trial Details

NCT Number	NCT07366086
Lead Sponsor	Amgen
Conditions	Osteogenesis Imperfecta
Enrollment	71 participants
Start Date	2026-03-18
Primary Completion	2028-04-19 (estimated)
Study Completion	2028-04-19 (estimated)
Updated on ClinicalTrials.gov	2026-06-22